Asset Management One’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Asset Management One’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9,373	Closed	-$428K	–	1290
2016 Q3	$428K	Hold	9,373	–	–	0.01%	1074
2016 Q2	$374K	Hold	9,373	–	–	0.01%	1112
2016 Q1	$326K	Hold	9,373	–	–	﹤0.01%	1154
2015 Q4	$403K	Hold	9,373	–	–	0.01%	1104
2015 Q3	$408K	Buy	9,373 +5,504	+142%	+$297K	0.01%	1105
2015 Q2	$200K	Hold	3,869	–	–	﹤0.01%	1246
2015 Q1	$151K	Hold	3,869	–	–	﹤0.01%	1284
2014 Q4	$149K	Buy	+3,869	New	+$148K	﹤0.01%	1209

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Asset Management One's BSTC Position: Q4 2016 in Review

Asset Management One sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2016, closing a stake of 9,373 shares — an estimated $428K sold.

Asset Management One first reported a position in BSTC in Q4 2014 and held it in 8 quarters. The position peaked at $428K in Q3 2016. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.

Asset Management One reported no remaining BioSpecifics Technologies Corp. position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 9,373 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $428K.
Asset Management One first reported a position in BioSpecifics Technologies Corp. in Q4 2014 and held it in 8 quarters.
Asset Management One's BioSpecifics Technologies Corp. position peaked at $428K in Q3 2016.
96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.